vs

Side-by-side financial comparison of Aramark (ARMK) and DaVita (DVA). Click either name above to swap in a different company.

Aramark is the larger business by last-quarter revenue ($4.8B vs $3.6B, roughly 1.3× DaVita). DaVita runs the higher net margin — 6.5% vs 2.0%, a 4.5% gap on every dollar of revenue. On growth, DaVita posted the faster year-over-year revenue change (12.3% vs 6.1%). Over the past eight quarters, Aramark's revenue compounded faster (7.3% CAGR vs 6.6%).

Aramark is an American food service and facilities services provider to clients in areas including education, prisons, healthcare, business, and leisure. It operates in North America and an additional 14 countries, including the United Kingdom, Germany, Chile, Ireland, and Spain.

DaVita Inc. is an American company that provides kidney dialysis services through a network of 2,675 outpatient centers in the United States, serving 200,800 patients, and 367 outpatient centers in 11 other countries serving 49,400 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.

ARMK vs DVA — Head-to-Head

Bigger by revenue
ARMK
ARMK
1.3× larger
ARMK
$4.8B
$3.6B
DVA
Growing faster (revenue YoY)
DVA
DVA
+6.2% gap
DVA
12.3%
6.1%
ARMK
Higher net margin
DVA
DVA
4.5% more per $
DVA
6.5%
2.0%
ARMK
Faster 2-yr revenue CAGR
ARMK
ARMK
Annualised
ARMK
7.3%
6.6%
DVA

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ARMK
ARMK
DVA
DVA
Revenue
$4.8B
$3.6B
Net Profit
$96.2M
$234.2M
Gross Margin
Operating Margin
4.5%
15.5%
Net Margin
2.0%
6.5%
Revenue YoY
6.1%
12.3%
Net Profit YoY
-9.0%
43.8%
EPS (diluted)
$0.36
$3.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARMK
ARMK
DVA
DVA
Q1 26
$4.8B
$3.6B
Q4 25
$5.0B
$3.6B
Q3 25
$3.4B
Q2 25
$4.6B
$3.4B
Q1 25
$4.3B
$3.2B
Q4 24
$4.6B
$3.3B
Q3 24
$4.4B
$3.3B
Q2 24
$4.4B
$3.2B
Net Profit
ARMK
ARMK
DVA
DVA
Q1 26
$96.2M
$234.2M
Q4 25
$87.1M
$234.2M
Q3 25
$150.3M
Q2 25
$71.8M
$199.3M
Q1 25
$61.9M
$162.9M
Q4 24
$105.6M
$259.3M
Q3 24
$122.4M
$214.7M
Q2 24
$58.1M
$222.7M
Operating Margin
ARMK
ARMK
DVA
DVA
Q1 26
4.5%
15.5%
Q4 25
4.3%
15.5%
Q3 25
14.8%
Q2 25
3.9%
15.9%
Q1 25
4.1%
13.6%
Q4 24
4.8%
17.2%
Q3 24
5.0%
16.4%
Q2 24
3.7%
15.9%
Net Margin
ARMK
ARMK
DVA
DVA
Q1 26
2.0%
6.5%
Q4 25
1.7%
6.5%
Q3 25
4.4%
Q2 25
1.6%
5.9%
Q1 25
1.4%
5.1%
Q4 24
2.3%
7.9%
Q3 24
2.8%
6.6%
Q2 24
1.3%
7.0%
EPS (diluted)
ARMK
ARMK
DVA
DVA
Q1 26
$0.36
$3.22
Q4 25
$0.33
$3.22
Q3 25
$2.04
Q2 25
$0.27
$2.58
Q1 25
$0.23
$2.00
Q4 24
$0.39
$3.08
Q3 24
$0.46
$2.50
Q2 24
$0.22
$2.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARMK
ARMK
DVA
DVA
Cash + ST InvestmentsLiquidity on hand
$439.6M
$700.7M
Total DebtLower is stronger
$6.2B
$10.2B
Stockholders' EquityBook value
$3.2B
$-651.1M
Total Assets
$13.5B
$17.5B
Debt / EquityLower = less leverage
1.94×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARMK
ARMK
DVA
DVA
Q1 26
$439.6M
$700.7M
Q4 25
$639.1M
$700.7M
Q3 25
$736.5M
Q2 25
$501.5M
$739.4M
Q1 25
$920.5M
$511.9M
Q4 24
$484.1M
$846.0M
Q3 24
$672.5M
$1.1B
Q2 24
$436.1M
$437.2M
Total Debt
ARMK
ARMK
DVA
DVA
Q1 26
$6.2B
$10.2B
Q4 25
$5.4B
$10.2B
Q3 25
$10.2B
Q2 25
$6.3B
$10.1B
Q1 25
$6.1B
$9.6B
Q4 24
$5.0B
$9.2B
Q3 24
$4.3B
$9.3B
Q2 24
$5.0B
$8.5B
Stockholders' Equity
ARMK
ARMK
DVA
DVA
Q1 26
$3.2B
$-651.1M
Q4 25
$3.1B
$-651.1M
Q3 25
$-571.9M
Q2 25
$3.1B
$-369.6M
Q1 25
$3.0B
$-267.1M
Q4 24
$3.1B
$121.1M
Q3 24
$3.0B
$386.7M
Q2 24
$2.9B
$632.9M
Total Assets
ARMK
ARMK
DVA
DVA
Q1 26
$13.5B
$17.5B
Q4 25
$13.3B
$17.5B
Q3 25
$17.6B
Q2 25
$13.3B
$17.5B
Q1 25
$13.5B
$17.1B
Q4 24
$12.7B
$17.3B
Q3 24
$12.7B
$17.5B
Q2 24
$12.5B
$17.0B
Debt / Equity
ARMK
ARMK
DVA
DVA
Q1 26
1.94×
Q4 25
1.71×
Q3 25
Q2 25
2.03×
Q1 25
2.02×
Q4 24
1.61×
75.76×
Q3 24
1.42×
23.95×
Q2 24
1.71×
13.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARMK
ARMK
DVA
DVA
Operating Cash FlowLast quarter
$-782.2M
Free Cash FlowOCF − Capex
$-904.4M
FCF MarginFCF / Revenue
-18.7%
Capex IntensityCapex / Revenue
2.5%
Cash ConversionOCF / Net Profit
-8.13×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARMK
ARMK
DVA
DVA
Q1 26
$-782.2M
Q4 25
$540.7M
Q3 25
$841.5M
Q2 25
$76.7M
$324.2M
Q1 25
$255.9M
$180.0M
Q4 24
$-587.2M
$547.6M
Q3 24
$1.0B
$810.4M
Q2 24
$140.7M
$798.8M
Free Cash Flow
ARMK
ARMK
DVA
DVA
Q1 26
$-904.4M
Q4 25
$395.3M
Q3 25
$675.4M
Q2 25
$-34.7M
$203.1M
Q1 25
$140.1M
$36.8M
Q4 24
$-707.0M
$377.0M
Q3 24
$882.3M
$671.4M
Q2 24
$55.6M
$674.1M
FCF Margin
ARMK
ARMK
DVA
DVA
Q1 26
-18.7%
Q4 25
10.9%
Q3 25
19.7%
Q2 25
-0.8%
6.0%
Q1 25
3.3%
1.1%
Q4 24
-15.5%
11.4%
Q3 24
20.0%
20.6%
Q2 24
1.3%
21.2%
Capex Intensity
ARMK
ARMK
DVA
DVA
Q1 26
2.5%
Q4 25
2.8%
4.0%
Q3 25
4.9%
Q2 25
2.4%
3.6%
Q1 25
2.7%
4.4%
Q4 24
2.6%
5.2%
Q3 24
3.2%
4.3%
Q2 24
1.9%
3.9%
Cash Conversion
ARMK
ARMK
DVA
DVA
Q1 26
-8.13×
Q4 25
2.31×
Q3 25
5.60×
Q2 25
1.07×
1.63×
Q1 25
4.14×
1.10×
Q4 24
-5.56×
2.11×
Q3 24
8.35×
3.77×
Q2 24
2.42×
3.59×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARMK
ARMK

Education$1.1B22%
Sports Leisure Corrections$961.2M20%
Food And Support Services International$847.8M18%
Other$621.6M13%
Businessand Industry$510.6M11%
Health Care$421.3M9%
Facility Services$382.9M8%

DVA
DVA

Segment breakdown not available.

Related Comparisons